INVESTABOT
Equity Research
XNYS · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
TL;DR: ResMed dismissed KPMG LLP as its independent auditor on August 13, 2026, ending the firm's role as the company's principal accountant. Auditor changes at large public companies are worth tracking — the choice of…
ResMed (RMD) had 1 Form 144 pre-sale notice filed on 2026-07-07. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
ResMed (RMD) had 1 Form 144 pre-sale notice filed on 2026-06-08. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
ResMed (RMD) had 1 Form 144 pre-sale notice filed on 2026-05-27. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
TL;DR: ResMed posted Q3 fiscal 2026 revenue of $1.43B, up 10.8% from $1.29B in the year-ago quarter, with GAAP gross margin expanding 290 basis points to 62.2%.
open-market Form 4 only - grants, exercises, tax withholding excluded
0 buyers - 3 unique sellers · 8 accumulating - 4 trimming - 2 unchanged
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| September 8, 2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | -4,991 | — | — |
| September 8, 2026 | Farrell Michael J. | Chairman and CEO | SELL | -4,991 | $222 | ~$1.1M |
| September 8, 2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | 4,991 | $146 | ~$0.7M |
| September 2, 2026 | Farrell Peter C | — | SELL | -970 | $235 | ~$0.2M |
| August 7, 2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | 4,991 | $146 | ~$0.7M |
| August 7, 2026 | Farrell Michael J. | Chairman and CEO | SELL | -4,991 | $206 | ~$1.0M |
| August 7, 2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | -4,991 | — | — |
| August 5, 2026 | Farrell Peter C | — | SELL | -8,000 | $225 | ~$1.8M |
| July 7, 2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | 4,991 | $146 | ~$0.7M |
| July 7, 2026 | Farrell Michael J. | Chairman and CEO | SELL | -4,991 | $219 | ~$1.1M |
| July 7, 2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | -4,991 | — | — |
| June 8, 2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | 4,991 | $146 | ~$0.7M |
| June 8, 2026 | Farrell Michael J. | Chairman and CEO | SELL | -4,991 | $194 | ~$1.0M |
| June 8, 2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | -4,991 | — | — |
| June 1, 2026 | Rider Michael J | Global General Counsel | TAX_WITHHOLD | -268.74 | $191 | ~$51K |
| May 7, 2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | 4,991 | $146 | ~$0.7M |
| May 7, 2026 | Farrell Michael J. | Chairman and CEO | SELL | -4,991 | $208 | ~$1.0M |
| May 7, 2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | -4,991 | — | — |
| April 7, 2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | 4,991 | $146 | ~$0.7M |
| April 7, 2026 | Farrell Michael J. | Chairman and CEO | SELL | -4,991 | $226 | ~$1.1M |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| September 8, 2026 | Farrell Michael J. | — | 4,991 | SEC |
| September 2, 2026 | Peter C Farrell | — | — | SEC |
| August 7, 2026 | Farrell Michael J. | — | 4,991 | SEC |
| August 5, 2026 | Peter C Farrell | — | — | SEC |
| July 7, 2026 | Farrell Michael J. | — | 4,991 | SEC |
| June 8, 2026 | Farrell Michael J. | — | 4,991 | SEC |
| May 27, 2026 | Sandercock Brett | — | 8,000 | SEC |
| May 7, 2026 | Farrell Michael J. | — | 4,991 | SEC |
| Date | Insider | Title | Relationship | Shares | Filing |
|---|---|---|---|---|---|
| May 4, 2026 | — | — | — | — | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 18,882,403 | ~$4.5B | — | January 29, 2026 |
| BlackRock | 12,348,652 | ~$3.0B | — | February 12, 2026 |
| BlackRock | 12,094,023 | ~$2.7B | -2.1% | May 13, 2026 |
| BlackRock | 12,317,194 | ~$2.4B | 1.9% | August 7, 2026 |
| BlackRock | 11,691,961 | ~$2.2B | — | August 13, 2024 |
| State Street | 6,625,408 | ~$1.6B | — | February 13, 2026 |
| State Street | 6,643,168 | ~$1.5B | 0.3% | May 15, 2026 |
| State Street | 6,680,735 | ~$1.3B | 0.6% | August 7, 2026 |
| Morgan Stanley | 2,891,697 | ~$696.5M | — | May 27, 2026 |
| Morgan Stanley | 2,686,821 | ~$603.1M | -7.1% | May 15, 2026 |
| Morgan Stanley | 1,928,931 | ~$375.9M | -28.2% | August 13, 2026 |
| Goldman Sachs | 979,419 | ~$235.9M | — | March 25, 2026 |
| Goldman Sachs | 1,160,426 | ~$226.1M | 15.6% | August 14, 2026 |
| Goldman Sachs | 1,004,205 | ~$225.4M | 2.5% | May 15, 2026 |
| AQR Capital | 910,623 | ~$177.1M | 160.3% | August 14, 2026 |
| JP Morgan Chase | 847,736 | ~$168.2M | 17.9% | August 12, 2026 |
| JP Morgan Chase | 719,347 | ~$158.3M | 18.8% | May 13, 2026 |
| JP Morgan Chase | 605,408 | ~$145.8M | — | February 11, 2026 |
| Citadel Advisors | 610,484 | ~$119.0M | 45.3% | August 14, 2026 |
| Fidelity (FMR) | 415,813 | ~$100.2M | — | February 17, 2026 |